NCT07547436

A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis

SUSPENDEDPHASE2INTERVENTIONAL

Trial Details

Start: 2026-06-08Est. Completion: 2027-10-29

Enrollment target: 70 participants

Locations

Pulmonary Associates - Phoenix - East McDowell Road- Site Number : 8400008, Phoenix, Arizona, United States
Advanced Pulmonary Research Institute- Site Number : 8400001, Loxahatchee Groves, Florida, United States
Hull and Hull Medical Specialists- Site Number : 8400002, Plantation, Florida, United States
Clinical Research Associates of Central Pennsylvania- Site Number : 8400006, DuBois, Pennsylvania, United States

Healthy ParticipantsNon-cystic Fibrosis Bronchiectasis

This is a Phase 1a/1b study to test the safety, tolerability, microbiological response, and pharmacokinetics of inhaled …

Miami, United StatesEst. completion Jun 2027

Non Cystic Fibrosis Bronchiectasis

the study will concentrate on the effect of High Frequency Chest Wall Oscillation compared to conventional pulmonary phy…

Asyut, EgyptEst. completion Dec 1, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.